The effects of this drug include the reduction of vascular endothelial growth factor (VEGF) expression, restriction of tumor angiogenesis [187], augmentation of T cell proliferation, improvement of NK cell functions [188], enhancement of expansion of NKT cells, and upregulation of the IFN-γ production in vivo and in vitro [189]. This evidence concerns the gene VEGFA and neoplasm.